These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5535341)

  • 1. Federal drug abuse programs: U.S.A.--some correlations with poisoning control.
    Carabillo EA
    Clin Toxicol; 1970 Mar; 3(1):13-8. PubMed ID: 5535341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Industrial secrecy and anti-poison centers].
    Demozay D; Vincent V
    Eur J Toxicol Hyg Environ; 1973; 6(6):266-74. PubMed ID: 4794473
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug abuse treatment programs. An emerging federal role.
    Miller DE
    Hospitals; 1971 Aug; 45(15):50-2 passim. PubMed ID: 5561833
    [No Abstract]   [Full Text] [Related]  

  • 4. The Bureau of Drug Abuse Control: a review of the first two years.
    Gunn JW
    J Forensic Sci; 1968 Jul; 13(3):302-17. PubMed ID: 5757498
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward better utilization of federal and state resources in the communication of poison information.
    Verhulst HL
    Clin Toxicol; 1970 Jun; 3(2):275-6. PubMed ID: 5527849
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of poison control statutes in the United States.
    Russell SL; Czajka PA
    Am J Hosp Pharm; 1984 Mar; 41(3):481-4. PubMed ID: 6702852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The internet and acute poisoning].
    Kiyota K
    Chudoku Kenkyu; 2009 Dec; 22(4):309-14. PubMed ID: 20058659
    [No Abstract]   [Full Text] [Related]  

  • 8. The drug information center movement: some correlations with poison control.
    Canada AT
    Clin Toxicol; 1970 Jun; 3(2):277-80. PubMed ID: 5527850
    [No Abstract]   [Full Text] [Related]  

  • 9. Federal response to drug abuse.
    Heistad GT
    Minn Med; 1973 Mar; 56(3):187-91. PubMed ID: 4734613
    [No Abstract]   [Full Text] [Related]  

  • 10. Advantages and disadvantages of combining poison control and drug information centers.
    Troutman WG; Wanke LA
    Am J Hosp Pharm; 1983 Jul; 40(7):1219-22. PubMed ID: 6881165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty five years of poison center experience with propoxyphene overdoses the FDA could not find.
    Hayes BD; Anderson BD
    Clin Toxicol (Phila); 2009 Nov; 47(9):905-6. PubMed ID: 19814605
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment: effect of scheduling tramadol as a controlled substance on poison center exposures to tramadol.
    Fass J
    Ann Pharmacother; 2010 Sep; 44(9):1509. PubMed ID: 20682851
    [No Abstract]   [Full Text] [Related]  

  • 13. Federal Food And Drug Administration. Revised New-Drug Regulations. Title 21--Food And Drugs.
    J Oral Ther Pharmacol; 1967 Sep; 4(2):148-64. PubMed ID: 6062044
    [No Abstract]   [Full Text] [Related]  

  • 14. Sources of regulatory information for pharmacists.
    Goldwire MA; Rumore MM
    Am J Hosp Pharm; 1993 Jun; 50(6):1175-81. PubMed ID: 8517457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 16. Federal drug and narcotic legislation.
    Young JH
    Pharm Hist; 1995; 37(2):59-67. PubMed ID: 11639645
    [No Abstract]   [Full Text] [Related]  

  • 17. The new Federal narcotic and dangerous drug law.
    Clark DA
    J Indiana State Med Assoc; 1971 Jun; 64(6):499-501. PubMed ID: 5124968
    [No Abstract]   [Full Text] [Related]  

  • 18. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison.
    Hughes AA; Bogdan GM; Dart RC
    Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug abuse and legislators. Methods and possibilities of an optimal control of drug and pharmaceutical abuse].
    von Wartburg WP
    Experientia Suppl; 1974; 21():1-474. PubMed ID: 4426361
    [No Abstract]   [Full Text] [Related]  

  • 20. [Central health and control authorities].
    Halse M
    Tidsskr Nor Laegeforen; 1977 Feb; 97(5):257-8. PubMed ID: 841564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.